Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 8/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | MME | P08473 | 4/20 | 0.45 |
| ▸ | ACE | P12821 | 4/20 | 0.45 |
| ▸ | CPA1 | P15085 | 2/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.44 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3678022 | 0.88 | TAAR1 (0.55) | MEN1KMT2ATAAR1CYP1A2CYP2D6 | |
| SCHEMBL8698887 | 0.83 | MME (0.46) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL7312539 | 0.81 | PPARG (0.41) | PPARGPPARAMEN1KMT2ATAAR1 | |
| SCHEMBL10590311 | 0.81 | MEN1 (0.41) | PPARGPPARAMEN1KMT2ATAAR1 | |
| SCHEMBL159574 | 0.79 | TP53 (0.58) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL16021181 | 0.79 | PPARG (0.42) | PPARGPPARAMEN1KMT2ATAAR1 | |
| SCHEMBL8283176 | 0.79 | TP53 (0.58) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL27760849 | 0.77 | SRR (0.41) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL332254 | 0.76 | SRR (0.46) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL1335887 | 0.76 | TAAR1 (0.50) | SRRPSAT1MMEACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 637 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114585615-A | Synthesis of 6-methyl-N1- (4- (pyridin-3-yl) pyrimidin-2-yl) benzene-1, 3-diamine | 新加坡艺思高艾斯特生物科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-108218903-B | Process for the preparation of L-BPA | 南京中硼联康医疗科技有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-111770928-A | Synthesis of oligonucleotides and nucleic acids | 埃万奈蒂克有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-108373479-B | Process for the preparation of L-BPA | 南京中硼联康医疗科技有限公司 | 2020-06-12 | — | — | CN | claimed |
| US-9822146-B2 | Process for the manufacture of degarelix and its intermediates | FERRING B.V. (NL) | 2017-11-21 | — | — | US | claimed |
| US-20160145301-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FERRING BV (NL) | 2016-05-26 | — | — | US | claimed |
| EP-2161277-B1 | Asymmetric synthesis of peptides | UNIV READING (GB) | 2013-04-10 | — | — | EP | claimed |
| US-8399612-B2 | Asymmetric synthesis of peptides | UNIVERSITY OF READING (GB) | 2013-03-19 | — | — | US | claimed |
| US-20120190816-A9 | ASYMMETRIC SYNTHESIS OF PEPTIDES | UNIVERSITY OF READING | 2012-07-26 | — | — | US | claimed |
| EP-2081919-B1 | TETRAHYDROFURO [3, 2-B]PYRR0L-3-0NE INTERMEDIATES | AMURA THERAPEUTICS LTD (GB) | 2012-05-23 | — | — | EP | claimed |
| EP-1660465-A2 | PROCESS FOR THE SYNTHESIS OF BIARYL OXAZOLIDINONES | Rib-X Pharmaceuticals, Inc. (US) | 2006-05-31 | — | — | EP | claimed |
| EP-1644401-A1 | IMPROVED PROCESS FOR SUPPORTED PHASE SYNTHESIS | UCB, S.A. (BE) | 2006-04-12 | — | — | EP | claimed |
| US-6958330-B1 | Polycyclic α-amino-ε-caprolactams and related compounds | ELAN PHARMACEUTICALS, INC. (US) | 2005-10-25 | — | — | US | claimed |
| WO-2005012271-A2 | PROCESS FOR THE SYNTHESIS OF BIARYL OXAZOLIDINONES | RIB-X PHARMACEUTICALS, INC. (US) | 2005-02-10 | — | — | WO | claimed |
| WO-2005005457-A1 | IMPROVED PROCESS FOR SUPPORTED PHASE SYNTHESIS | UCB, S.A. (BE) | 2005-01-20 | — | — | WO | claimed |
| WO-2004013139-A2 | PROCESS FOR PREPARING 7-AZAINDOLES | EISAI CO., LTD (JP) | 2004-02-12 | — | — | WO | claimed |
| EP-0376218-B1 | Racemization free attachment of amino acids to solid phase | PERSEPTIVE BIOSYSTEMS INC (US) | 1999-02-24 | — | — | EP | claimed |
| US-5187270-A | Solid phase synthesis of peptides using the reaction product of an N-protected amino acid and a 2,4-dichlorophenyl (4-halo methylphenoxy)acetate; efficiency; purity; kinetics | MILLIPORE CORPORATION (US) | 1993-02-16 | — | — | US | claimed |
| EP-0376218-A2 | Racemization free attachment of amino acids to solid phase | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1990-07-04 | — | — | EP | claimed |
| US-3944590-A | ALKYL PHENYL CARBONATES | CIBA-GEIGY CORPORATION (US) | 1976-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145301-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | VIP, HABP2, DPP9 | SRR 1740/4885PSAT1 3757/4885PPARG 4643/4885 |
| US-20120190816-A9 | ASYMMETRIC SYNTHESIS OF PEPTIDES | PTMS, NGLY1, QPCT | SRR 32/4885PSAT1 1115/4885PPARG 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.